Clinical Trials Sponsored by National Institute of Drug Abuse

Total 28159 results

University of Arkansas
National Institute on Drug Abuse (NIDA)

Completed

Clinical Efficacy of Atomoxetine for Methamphetamine Dependence (ATM)

Methamphetamine Dependence

United States
National Institute on Drug Abuse (NIDA)
University of Minnesota

Completed

Effects of Phenytoin on Cocaine Use in Humans - 2

Cocaine-Related Disorders

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1

Alcoholism | Alcohol-Related Disorders | Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Pennsylvania

Completed

Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Pennsylvania

Completed

Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1

Opioid-Related Disorders

United States
University of Washington

Completed

HIV/STD Safer Sex Skills Groups for Men in Drug Treatment Programs - 1

Behavior Therapy

United States
National Institute on Drug Abuse (NIDA)
University of Pennsylvania

Completed

Buprenorphine Maintenance for Opiate Dependence - 6

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Texas

Completed

Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3

Opioid-Related Disorders | Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Minnesota

Completed

Acute Withdrawal From Smoked Cocaine - 9

Substance-Related Disorders | Substance Withdrawal Syndrome | Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Texas

Completed

Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4

Alcohol-Related Disorders | Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Minnesota

Completed

Role of Metabolites in Nicotine Dependence (2) - 5

Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)
University of Pennsylvania

Completed

Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Arkansas
National Institute on Drug Abuse (NIDA)

Completed

Monoamine Antagonist Therapies for Methamphetamine Abuse Prazosin (MATMA)

Continuous Methamphetamine Abuse

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Attempts to Stop/Reduce Marijuana Among Dependent Users

Marijuana Abuse | Marijuana Dependence

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Methadone Maintenance & HIV Risk in Ukraine

Opioid Dependence

Ukraine
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

HIV Risk Reduction in Subutex Injectors in Tbilisi

HIV

Georgia
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Detox With Two Types of Treatment. BBD II - 11

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate-Day Buprenorphine Administration. Phase VIII - 9

Opioid-Related Disorders

United States
University of Michigan
National Institute on Drug Abuse (NIDA)

Completed

Healthier You: Optimizing Screening, Brief Interventions, and Referral to Treatment (SBIRT) in the Emergency Department

Drug Abuse

United States
University of Miami
National Institute on Drug Abuse (NIDA)

Completed

Culturally Informed Family Based Treatment of Adolescents: A Randomized Trial (CIFFTA)

Risk Behavior | Substance Use Disorders | Psychiatric Disorders | Family Dysfunction

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Miami
National Institute on Drug Abuse (NIDA)

Completed

Juvenile Offender HIV Prevention and Drug Abuse Services (Day Treatment)

Risk Behavior | Substance Abuse | Delinquency

United States
University of Michigan
National Institute on Drug Abuse (NIDA)

Completed

Developing Violence Prevention Therapy for Substance Abusers

Substance Use Disorders | Violence

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22

Opioid-Related Disorders | Cocaine-Related Disorders

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Role of Instructions in Nitrous Oxide Effects and Choice - 10

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Isoflurane at Subanesthetic Concentrations - 6

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Gepirone vs Placebo in Treatment of Cocaine Dependence - 3

Cocaine-Related Disorders

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Effects of Nitrous Oxide: A Dose-Response Analysis - 5

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Michigan
National Institute on Drug Abuse (NIDA)

Completed

Developing an Intervention to Address Suicide Risk During Substance Use Disorder

Substance-Related Disorders | Suicide

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Effects of MDMA on Social and Emotional Processing

Drug Addiction

United States
University of Pittsburgh
National Institute on Drug Abuse (NIDA)

Completed

The Effect of Exercise on Acute Nicotine Withdrawal (NicEx)

Smoking | Sleep Disorders, Intrinsic | Nicotine Dependence

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Neural Substrates in Nicotine Withdrawal

Tobacco Use Disorder

United States
University of Pittsburgh
National Institute on Drug Abuse (NIDA)

Completed

RCT of High- vs. Standard-Calorie Formula for Methadone-Exposed Infants

Neonatal Abstinence Syndrome

United States
University of Cincinnati
National Institute on Drug Abuse (NIDA)

Unknown

Targeted Intervention for Bipolar Smokers

Bipolar Disorder | Nicotine Dependence

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Gradual vs. Abrupt Cessation Treatment for Smoking

Smoking Cessation

United States
University of Pittsburgh
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana Dependence (CADY)

Depressive Disorder, Major | Cannabis Abuse

United States
University of Kentucky
National Institute on Drug Abuse (NIDA)

Completed

Agonist Replacement Therapy for Cocaine Dependence

Cocaine Dependence

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Patient Feedback Effectiveness Study

Substance Use Disorders

United States
University of Oregon
National Institute on Drug Abuse (NIDA)

Completed

A Family Intervention for Adolescent Problem Behavior (AKA Project Alliance 2) (PAL-2)

Depression | Anxiety | Conduct Disorder | Substance Use

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 21

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase X - 15

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase XII - 17

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detox With Two Types of Treatment. BBD I - 10

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase II - 4

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase VII - 8

Opioid-Related Disorders

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use (ROLDI)

Opioid Use Disorder
University of Louisville
National Institute on Drug Abuse (NIDA)

Recruiting

Supporting Resilience Among Re-entered Seniors (SRRS)

Chronic Disease

United States
University of Washington
National Institute on Drug Abuse (NIDA)

Recruiting

Combination Primary Care and Prevention Services for Women Who Inject Drugs and Exchange Sex in Seattle, Washington

HIV Infections | Opioid Use Disorder | Chlamydia | Gonorrhea | Syphilis | Trichomonas

United States
University of Kentucky
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Cannabis and Opioid Use Disorder

Opioid Use Disorder

Clinical Trials Sponsored by National Institute of Drug Abuse

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations